
Goodpasture antigen
Collagen type IV NC1 domainSource: Bovine Kidney
Catalogue Number: ATG02-02
Product Information
Patients with Goodpasture syndrome can exhibit clinical features typical of autoimmune vasculitic conditions. It has therefore been recommended that anti-GBM antibodies be assayed together with anti-neutrophil cytoplasmic antibodies (ANCA) in pulmonary renal syndromes.
Anti-GBM antibodies distribute along the GBM in a linear fashion as seen by direct immunofluorescence microscopy, indicative of reactivity with a specific GBM antigen that has been identified as the NC1 domain of α3 type IV collagen. Collagen IV interweaves with laminins, nidogen and sulphated proteoglycans to assemble basement membranes. In glomerular basement membrane three distinct α chains (α3.α4.α5) of type IV collagen assemble as a triple helical protomer with their respective C-terminal non-collagenous domains (NC1) forming a trimer at one extreme.
Two NC1 trimers unite to form a hexamer; these hexamers create collagenous networks by uniting four triple helical 7S domains at the N-terminal. Super-coiling and disulphide bridges further stabilise the network. Two dominant epitopes have been identified on α3(IV) NC1, both of which are cryptic in nature and inaccessible for autoantibody binding unless dissociation of the NC1 hexamer occurs. The epitopes appear to be conformation-dependent and are destroyed by reduction of disulphide bridges.
Clinical Indications
Goodpasture's syndrome
MSDS
References
Lerner, R.A. et al. (1967) J. Exp. Med. 126, 989
Lockwood, C.M. et al. (1976) Lancet 1: 711
Hellmark, T. et al. (1997) Nephrol. Dial. Transpl. 12, 646
Kline-Bolton, W. (1966) Kidney Int. 50, 1753
Peters, D.K. et al. (1982) Trans. Proc. 14, 513
Bygren, P. et al. (1992) Eur. J. Clin. Inv. 22, 783
Westman, K.W.A. et al. (1997) Nephrol. Dial. Transpl. 12, 1863
Sheer, R.L. & Grossman, M.A. (1964) Ann. Intern. Med. 60, 1009
Saus, J. et al. (1988) J. Biol. Chem. 263, 13374
Yurchenko, P.D. et al. (2002) Meth. Cell Biol. 69, 111
Borza, D.B. et al. (2002) J. Biol. Chem. 277, 40075
Hudson, B.G. et al. (2003) New Engl. J. Med. 348, 2543
Borza, D.B. et al. (2000) J. Biol. Chem. 275, 6030
Gunnarson, A. et al. (2000) J. Biol. Chem. 275, 30844
David, M. et al. (2001) J. Biol. Chem. 276, 6370
Hellmark, T. et al. (1996) Clin. Exp. Immunol. 105, 504
Kalluri, R. et al. (1996) Ann. Intern. Med. 124, 651
Ryan, J.J. et al. (1998) Nephrol. Dial. Transpl. 13, 602
Hellmark, T. et al. (1997) J. Am. Soc. Nephrol. 8, 376
Gunwar, S. et al. (1991) J. Biol. Chem. 266, 15318
Saxena, R. et al. (1989) J. Immunol. Meth. 118, 73